Novo Nordisk A/S
F:NOVC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
Novo Nordisk A/S
F:NOVC
|
DK |
|
Suncor Energy Inc
TSX:SU
|
CA |
|
Gan Ltd
NASDAQ:GAN
|
US |
|
YPF SA
NYSE:YPF
|
AR |
|
Pros Holdings Inc
NYSE:PRO
|
US |
|
4DMedical Ltd
ASX:4DX
|
AU |
|
Pets at Home Group PLC
LSE:PETS
|
UK |
|
ACADIA Pharmaceuticals Inc
NASDAQ:ACAD
|
US |
|
Paymentus Holdings Inc
NYSE:PAY
|
US |
|
Aptose Biosciences Inc
TSX:APS
|
CA |
|
Bridgewater Bancshares Inc
NASDAQ:BWB
|
US |
|
Bureau Veritas SA
F:4BV0
|
FR |
|
P
|
Pierre et Vacances SA
F:PV6
|
FR |
|
Nuvista Energy Ltd
TSX:NVA
|
CA |
|
DHT Holdings Inc
NYSE:DHT
|
BM |
|
A
|
ALM Equity AB
STO:ALM
|
SE |
|
C
|
CSP International Fashion Group SpA
MIL:CSP
|
IT |
|
C
|
Christian Dior SE
OTC:CHDRY
|
FR |
|
T
|
TotalEnergies SE
F:TOTA
|
FR |
|
N
|
Nano One Materials Corp
SWB:LBMB
|
CA |
|
E
|
EBR Systems Inc
ASX:EBR
|
US |
|
Eupraxia Pharmaceuticals Inc
TSX:EPRX
|
CA |
Bankruptcy Probability
Novo Nordisk A/S's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Novo Nordisk A/S Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
297.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
186.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
146.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DE |
|
Bayer AG
XETRA:BAYN
|
34.9B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
549.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
210.2B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
221B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Novo Nordisk A/S's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Novo Nordisk A/S has total debt of 118.9B DKK. This includes both short-term (0 DKK) and long-term (118.9B DKK) debt.
You can find a full breakdown on its Balance Sheet.
